To date, more than 200 CYP21A2 mutations have been identified [3], and most people with CAH are compound heterozygotes with different mutations on each allele and a phenotype associated with the milder gene defect [3]. This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.